6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-6-azabicyclo[3.2.0]heptane
Structure Info
- Chemspace ID
- CSSB02195990645 (In-Stock Building Blocks)
- IUPAC Name
- 6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-6-azabicyclo[3.2.0]heptane
- Mol formula
- C19H26BNO3
- Mol weight
- 327 Da
- Catalog Number(s)
- BBLS02195990645, BBV-284582852, EN300-55398935, bbls02195990645
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.8
- Heavy atoms count
- 24
- Rotatable bond count
- 2
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.631
- Polar surface area (Å)
- 39
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
![Chemical structure of 6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-6-azabicyclo[3.2.0]heptane (C19H26BNO3) - CSSB02195990645](/st/structure/200/1678ca5aca475cbe5c93e83b6cb009ad/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CC2CCCC12.png "C19H26BNO3")
- Zoom the structure
- CSSB02195990645
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 360.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 376.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 393.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 410.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 427.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 838.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,240.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 1,839.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of 6-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-6-azabicyclo[3.2.0]heptane - CSSB00777468817](/st/structure/200/9f35873707d10e6814cea3dca9ef9aab/CC1%253DCC%253DC%2528C%253DC1B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1%2529C%2528%253DO%2529N1CC2CCCC12.png)
![Chemical structure of 6-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-6-azabicyclo[3.2.0]heptane - CSSB02533511681](/st/structure/200/ff21889c57543be58ed26265d4059ceb/CC1%253DCC%253DC%2528C%253DC1C%2528%253DO%2529N1CC2CCCC12%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
Similarity Analogs
![Chemical structure of rac-(1R,6R)-7-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-7-azabicyclo[4.2.0]octane - CSSB21331611844](/st/structure/200/e793dfb030a2b51e155bef020eec68c7/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%2528%253DCC%253DC1%2529C%2528%253DO%2529N1C%255BC%2540H%255D2CCCC%255BC%2540%2540H%255D12%2B%257C%25261%253A19%252C24%252Cr%257C.png)
![Chemical structure of rac-(1R,6R)-7-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-7-azabicyclo[4.2.0]oct-3-ene - CSSB21331630653](/st/structure/200/797965ab05431db57a81f7ac5d28e99a/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%2528%253DCC%253DC1%2529C%2528%253DO%2529N1C%255BC%2540H%255D2CC%253DCC%255BC%2540%2540H%255D12%2B%257C%25261%253A19%252C24%252Cr%257C.png)
![Chemical structure of 7-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-3-oxa-7-azabicyclo[4.2.0]octane - CSSB02229496728](/st/structure/200/89fe7f17120b1c2890294c865d155654/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CC2COCCC12.png)
![Chemical structure of 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-octahydrocyclopenta[b]pyrrole - CSSB02229494050](/st/structure/200/3a64b9a1e7d70d1627e5df84fcfa78fa/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCC2CCCC12.png)
![Chemical structure of rac-(3aR,6aR)-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-octahydrocyclopenta[b]pyrrole - CSSB21332841571](/st/structure/200/591f342d23d3daa349808c4c1d4360cb/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%2528%253DCC%253DC1%2529C%2528%253DO%2529N1CC%255BC%2540H%255D2CCC%255BC%2540%2540H%255D12%2B%257C%25261%253A20%252C24%252Cr%257C.png)
![Chemical structure of (2R)-2-cyclobutyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine - CSSB20809158062](/st/structure/200/57a89fbb1abeb4228092d4b6933c752f/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%2528%253DCC%253DC1%2529C%2528%253DO%2529N1CC%255BC%2540%2540H%255D1C1CCC1.png)
![Chemical structure of (2S)-2-cyclobutyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine - CSSB20809181634](/st/structure/200/10c7aaa0b363d718f4b34973f3f4c1ea/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%2528%253DCC%253DC1%2529C%2528%253DO%2529N1CC%255BC%2540H%255D1C1CCC1.png)
